Literature DB >> 24357458

Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma.

Roshan Mahabir1, Mishie Tanino, Aiman Elmansuri, Lei Wang, Taichi Kimura, Tamio Itoh, Yusuke Ohba, Hiroshi Nishihara, Hiroki Shirato, Masumi Tsuda, Shinya Tanaka.   

Abstract

BACKGROUND: Ionizing irradiation is an effective treatment for malignant glioma (MG); however, a higher rate of recurrence with more aggressive phenotypes is a vital issue. Although epithelial-mesenchymal transition (EMT) is involved in irradiation-induced cancer progression, the role for such phenotypic transition in MG remains unknown.
METHODS: To investigate the mechanism of irradiation-dependent tumor progression in MG, we performed immunohistochemistry (IHC) and qRT-PCR using primary and recurrent MG specimens, MG cell lines, and primary culture cells of MG. siRNA technique was used for MG cell lines.
RESULTS: In 22 cases of clinically recurrent MG, the expression of the mesenchymal markers vimentin and CD44 was found to be increased by IHC. In paired identical MG of 7 patients, the expression of collagen, MMPs, and YKL-40 were also elevated in the recurrent MGs, suggesting the The Cancer Genome Atlas-based mesenchymal subtype. Among EMT regulators, sustained elevation of Snail was observed in MG cells at 21 days after irradiation. Cells exhibited an upregulation of migration, invasion, numbers of focal adhesion, and MMP-2 production, and all of these mesenchymal features were abrogated by Snail knockdown. Intriguingly, phosphorylation of ERK1/2 and GSK-3β were increased after irradiation in a Snail-dependent manner, and TGF-β was elevated in both fibroblasts and macrophages but not in MG cells after irradiation. It was noteworthy that irradiated cells also expressed stemness features such as SOX2 expression and tumor-forming potential in vivo.
CONCLUSIONS: We here propose a novel concept of glial-mesenchymal transition after irradiation in which the sustained Snail expression plays an essential role.

Entities:  

Keywords:  Snail; The Cancer Genome Atlas (TCGA); epithelial-mesenchymal transition (EMT); irradiation; malignant glioma

Mesh:

Substances:

Year:  2013        PMID: 24357458      PMCID: PMC3984547          DOI: 10.1093/neuonc/not239

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  53 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition.

Authors:  Ulf D Kahlert; Donata Maciaczyk; Soroush Doostkam; Brent A Orr; Brian Simons; Tomasz Bogiel; Thomas Reithmeier; Marco Prinz; Jörg Schubert; Gabriele Niedermann; Thomas Brabletz; Charles G Eberhart; Guido Nikkhah; Jaroslaw Maciaczyk
Journal:  Cancer Lett       Date:  2012-05-28       Impact factor: 8.679

3.  Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

Authors:  Christopher E Pelloski; E Lin; Li Zhang; W K Alfred Yung; Howard Colman; Juinn-Lin Liu; Shaio Y Woo; Amy B Heimberger; Dima Suki; Michael Prados; Susan Chang; Fredrick G Barker; Gregory N Fuller; Kenneth D Aldape
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

Review 4.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

Review 5.  The EMT regulator slug and lung carcinogenesis.

Authors:  Jin-Yuan Shih; Pan-Chyr Yang
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

6.  Gene Regulation of Prominin-1 (CD133) in Normal and Cancerous Tissues.

Authors:  Kouichi Tabu; Norihisa Bizen; Tetsuya Taga; Shinya Tanaka
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Human Slug is a repressor that localizes to sites of active transcription.

Authors:  K Hemavathy; S C Guru; J Harris; J D Chen; Y T Ip
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

8.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

Authors:  Jörg van den Boom; Marietta Wolter; Rork Kuick; David E Misek; Andrew S Youkilis; Daniel S Wechsler; Clemens Sommer; Guido Reifenberger; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 9.  Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis.

Authors:  Josef Gotzmann; Mario Mikula; Andreas Eger; Rolf Schulte-Hermann; Roland Foisner; Hartmut Beug; Wolfgang Mikulits
Journal:  Mutat Res       Date:  2004-01       Impact factor: 2.433

10.  A simplified approach for the molecular classification of glioblastomas.

Authors:  Marie Le Mercier; Delfyne Hastir; Xavier Moles Lopez; Nancy De Nève; Calliope Maris; Anne-Laure Trepant; Sandrine Rorive; Christine Decaestecker; Isabelle Salmon
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more
  78 in total

1.  Lower MGMT expression predicts better prognosis in proneural-like glioblastoma.

Authors:  Zhi-Cheng He; Yi-Fang Ping; Sen-Lin Xu; Yong Lin; Shi-Cang Yu; Hsiang-Fu Kung; Xiu-Wu Bian
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition.

Authors:  Diana Matias; Joana Balça-Silva; Luiz Gustavo Dubois; Bruno Pontes; Valéria Pereira Ferrer; Luciane Rosário; Anália do Carmo; Juliana Echevarria-Lima; Ana Bela Sarmento-Ribeiro; Maria Celeste Lopes; Vivaldo Moura-Neto
Journal:  Cell Oncol (Dordr)       Date:  2017-04-11       Impact factor: 6.730

Review 3.  Profiles of Radioresistance Mechanisms in Prostate Cancer.

Authors:  Luksana Chaiswing; Heidi L Weiss; Rani D Jayswal; Daret K St Clair; Natasha Kyprianou
Journal:  Crit Rev Oncog       Date:  2018

4.  ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.

Authors:  Ulf D Kahlert; Abigail K Suwala; Eric H Raabe; Florian A Siebzehnrubl; Maria J Suarez; Brent A Orr; Eli E Bar; Jaroslaw Maciaczyk; Charles G Eberhart
Journal:  Brain Pathol       Date:  2015-02-08       Impact factor: 6.508

5.  Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility.

Authors:  Min Yu; Wenjing Li; Qianqian Wang; Yan Wang; Fei Lu
Journal:  Oncogene       Date:  2018-05-18       Impact factor: 9.867

6.  Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.

Authors:  Jian Teng; Cintia C da Hora; Rami S Kantar; Ichiro Nakano; Hiroaki Wakimoto; Tracy T Batchelor; E Antonio Chiocca; Christian E Badr; Bakhos A Tannous
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

7.  Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence.

Authors:  Matthew D Wood; Gerald F Reis; David E Reuss; Joanna J Phillips
Journal:  J Neuropathol Exp Neurol       Date:  2016-08-18       Impact factor: 3.685

8.  miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition.

Authors:  Kazuhiro Yachi; Masumi Tsuda; Shinji Kohsaka; Lei Wang; Yoshitaka Oda; Satoshi Tanikawa; Yusuke Ohba; Shinya Tanaka
Journal:  Signal Transduct Target Ther       Date:  2018-12-28

9.  Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.

Authors:  Nusrat Jahan; Jae M Lee; Khalid Shah; Hiroaki Wakimoto
Journal:  Int J Cancer       Date:  2017-07-19       Impact factor: 7.396

10.  Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma.

Authors:  Yasuo Iwadate; Tomoo Matsutani; Seiichiro Hirono; Natsuki Shinozaki; Naokatsu Saeki
Journal:  J Neurooncol       Date:  2016-05-18       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.